Global Trust Asset Management LLC cut its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 20.0% in the third ...

There isn't any guarantee that the company will be a good investment on the force or direction of those trends alone. But ...

Most stocks offer high yields or growth, but the Schwab U.S. Dividend Equity ETF offers surprisingly strong growth, ...

The pharmaceutical company’s stock is relatively cheap, representing an opportunity for patient value investors.

Foundation has awarded Baylor College of Medicine Global Health $2.25 million (about K3.9 billion) for a three-year ...

Equities researchers at Leerink Partnrs decreased their Q3 2024 EPS estimates for Bristol-Myers Squibb in a research report ...

Fintel reports that on October 25, 2024, Citigroup downgraded their outlook for Bristol-Myers Squibb (NYSE:BMY) from Buy to ...

A newly described stage of a lymph node-like structure seen in liver tumors after presurgical immunotherapy may be vital to ...

Clinical trials of single-agent targeted drugs have shown limited efficacy. In the only trial of single-agent immunotherapy ...

A risk stratification algorithm may be able to predict which patients with advanced chronic liver disease are at risk of ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that ...

The healthcare sector has performed well in recent months, driven by the booming weight-loss drug treatment segment. Its ...